|
|
1.
|
Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial. MedStar authors:
- Waksman, Ron
- Weissman, Neil J
Year: 2013
Citation: - Lancet. 381(9869):836-44, 2013 Mar 9.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
- Clinical Trial
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
All authors: - Bose D, Degen H, Erbel R, Erne P, Haude M, Koolen J, Prati F, Verheye S, Vermeersch P, Waksman R, Weissman N, Wijnbergen I
|
